About us Pricing ContactSubscribe

J

José Baselga

Universitat Autònoma de BarcelonaORCID https://orcid.org/0000-0003-1361-4063

h-index

—

Publications

—

Citations

—

i10-index

—

Impact (2-yr)

—

Top Publications

Tumor mutational load predicts survival after immunotherapy across multiple cancer types

Nature Genetics20194,300 citations

Mutational landscape of metastatic cancer revealed from prospective clinical sequencing of 10,000 patients

Nature Medicine20173,455 citations

mTOR Inhibition Induces Upstream Receptor Tyrosine Kinase Signaling and Activates Akt

Cancer Research20062,544 citations

Radiotherapy plus cetuximab for locoregionally advanced head and neck cancer: 5-year survival data from a phase 3 randomised trial, and relation between cetuximab-induced rash and survival

The Lancet Oncology20091,965 citations

Tailoring therapies—improving the management of early breast cancer: St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2015

Annals of Oncology20151,820 citations

De-escalating and escalating treatments for early-stage breast cancer: the St. Gallen International Expert Consensus Conference on the Primary Therapy of Early Breast Cancer 2017

Annals of Oncology20171,245 citations

The Epidermal Growth Factor Receptor Pathway: A Model for Targeted Therapy

Clinical Cancer Research2006901 citations

Therapy-Related Clonal Hematopoiesis in Patients with Non-hematologic Cancers Is Common and Associated with Adverse Clinical Outcomes

Cell stem cell2017829 citations

José Baselga · Scinovex